Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients (Q63285817)

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Mattia Albiero

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

7

Elisabetta Iori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

11

Angelo Avogaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

5

Lisa Menegazzo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

4

Roberta Cappellari

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

2

Mauro Rigato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

3

Federico Boscari

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

author name string

Chiara Pilutti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Mariacristina Marescotti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Mario Plebani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

publication date

April 2015

0 references

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

volume

67-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

page(s)

21-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

Diabetes mellitus, fasting glucose, and risk of cause-specific death

27 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Endothelial dysfunction in diabetes: the role of reparatory mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Potential manipulation of endothelial progenitor cells in diabetes and its complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Diabetes impairs stem cell and proangiogenic cell mobilization in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Nomenclature of monocytes and dendritic cells in blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Monocyte-macrophage polarization balance in pre-diabetic individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Circulating endothelial progenitor cells and cardiovascular outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

New cholesterol guidelines: worth the wait?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Discontinuation of statins in routine care settings: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Discontinuation of statins among patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Statin discontinuation in high-risk patients: a systematic review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Statin rebound or withdrawal syndrome: does it exist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Novel mechanistic and clinical implications concerning the safety of statin discontinuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Effect of withdrawal of statin on C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

ATP-binding cassette transporters, atherosclerosis, and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Nonbone Marrow-Derived Circulating Progenitor Cells Contribute to Postnatal Neovascularization Following Tissue Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Arterio-venous gradient of endothelial progenitor cells across renal artery stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

In vitro neovasculogenic potential of resident adipose tissue precursors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

Nice neighborhood: emerging concepts of the stem cell niche

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.005

10.1016/J.VPH.2014.11.005

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25483979%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference